Attorney John Uustal Secures $6.5 Million for Whistleblower

A spokesperson for the Office of the Inspector General, who was involved in the case, commented, “Pharmaceutical companies that ignore rules designed to protect patients will be held accountable. Patients must be able to trust that decisions made by their doctors are based on unbiased professional judgment and not personal gain.” The U.S. Attorney has especially thanked Bergman for being brave enough to come forward and assist the government in ending the alleged misconduct by a known violator. He emphasized the importance of whistleblowers to shine a light on fraud. “Ms. Bergman’s efforts and those of her attorneys [Uustal et al.] were critical to our favorable resolution of this case.”

Read full article on whistleblower.org, here.

John Uustal Interviewed by DBR for ‘Litigation Leaders’ Segment

John Uustal, Founding Partner of Kelley | Uustal Trial Attorneys was recently interviewed by the Daily Business Review for their Litigation Leaders segment to learn how he ‘made things work’ during the…

K|U Attorney Cristina Pierson Featured in DBR for Braman Motors Class Action

A high-stakes race in the Broward Circuit Court pits a well-known dealership against a customer who is relying upon a rarely cited Florida law in alleging inflated labor costs in car service. Kelley…

Former Miami-Dade Assistant Public Defender Fan Li Joins Kelley | Uustal

We are pleased to announce that Fan Li, a Harvard Law School graduate with one of the most impressive trial track records ever at the Miami-Dade County Public Defender’s office, has…